American pharma & biotech Project, Program, and Portfolio Management

18th ANNUAL 2-Day Conference

Project, Program, and Portfolio Management Summit with a focus on Biopharma Portfolio Strategies

KEY TOPICS

The best practice case studies on how to build a portfolio function in an organization and how it evolves to mature portfolio management organisation.
What is the role of project management in different levels of maturity of PPM in different organisations?
How to prioritize projects, what methodologies to use for risk and decision analysis?

Building a winning cross functional team, working with external stakeholders.
Considering market access.
Utilizing new ways of working including agile and digital tools.
Working with innovation, working with mature products, working in R&D projects, working in manufacturing.

EVENT FEATURES

LEARNING

Hear from 30 speakers across 28 case-studies, panel discussions, workshop sessions, and keynote presentations to find industry trends, benchmark your work, and learn new strategies

INNOVATION

Learn about the rise of PPM as a management discipline and how PPM is driving innovation. See why projects are the future and how to develop high-performing people managers to maximize workforce effectiveness

NETWORKING

Explore the event's Networking features to meet industry peers, share challenges, discuss opportunities, and find new approaches

2023 EVENT SPEAKERS

Erik Adams

Global Director, Program and Project Management at CAI

Sachin Raje

Director, Strategy Realization Office, MRL GMSA at Merck

Stephen Smith

Project Team Lead

Mark Christopulos

R&D Portfolio Manager

Monika Sharma

Vice President, Product Development & Leadership at Wugen

Ailsa Mendez

Executive Director, Biotech Portfolio Lead at PPD

Elke Vogt

Site Head, Program Management at Thermo Fisher Scientific

Darshan Shah

Senior Director at Incyte

Mark Kleinman

Senior Project Director at CSL Behring

Sheila Woodhouse

Senior Director, Digital Health Lead, Global Drug Development at Bristol Myers Squibb

Lee Lambert

CEO at Lambert Consulting Group

Sathiya Prabaharan

Senior Director at Integra LifeSciences

Richard Sonnenblick

Chief Data Scientist at Planview

Joshua Hattem

Principal at ZS Associates

Estelle Paysinger Hill

Associate Director, Nonclinical Project Management at Sangamo Therapeutics

Allison Montalvo

Senior Director Oncology Cell Therapy Project Management at Johnson & Johnson

Vincent Turula

Senior Director at LEXEO Therapeutics

Paul Moss

Head of Sales at Intelligencia

Brooke Duffy

Chief Revenue Officer at Captario

Nara Gubbala

Principal PPM consultant at Gubbala Inc.

Richard Bayney

President & Founder, Portfolio Manager & Decision Analysist at PPVC

Josue Barnes

NNIH Fellow, Weill Cornell School of Medicine, NIH TL1 Fellow at Weill

Derek Shannon

Director, Statistical Project Management at Madrigal Pharmaceuticals

Anthonise Louis Fields

Senior Director, Team Lead at Bristol Myers Squibb

Destardi Moye-Sherman

Vice President, Program Management at Immunome, Inc.

Eric Laegen

Director, Project Management Team Leader at Johnson & Johnson

Kyle Derstine

Principal Portfolio Manager, Product Development at Genentech

Rose Blackburne

VP Global Product Development at Thermo Fisher Scientific

Shawn Martin

Senior Director, Head of Accelerando Critical Phase Program Management at Johnson & Johnson

Corky LaVallee

Global Program Team Director at EQRx

Show More Speakers

From our previous events

Testimonials

A great event with many open-minded (non-competing) participants that are willing to share their thoughts openly on many different, highly relevant topics.

Enjoyed many of the virtual presentations. Information was well organized, thorough, and to the topic.

Great relevant content and great speakers - very knowledgeable presenters with great presentation formats.

“I particularly enjoyed a variety of interesting topics on the agenda, knowledgeable speakers, participants and a great opportunity for networking”

“The topics were well chosen and the presentations well prepared. The opportunity to exchange thoughts and ideas with the participants was great!”

An event where everyone could participate in the conversation. Great mix of Panel discussion, round table and presentations that give the ability to network and meet everyone in the room.

AGENDA

View all speakers, sessions,
and their descriptions

REGISTRATION

$ 2349

Access to All Conference Sessions
Access to Post Conferences Networking
Conference Materials
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch

$ 2399

Renowned Decision Analysis Portfolio Management Masterclass with Industry Veteran Dr. Richard Bayney.
Individual consultancy with the trainer
Colored hardcopy of training materials in a binder
Electronic copy of trainer's textbook
Certificate of completion issued by the trainer

$ 3749

Grants all Masterclass and Conference Ticket Benefits including access to the Decision Analysis Portfolio Management Masterclass + 18th American Pharma and Biotech Project, Program and Portfolio Management Conference at a special rate.

SAVE $999

Present on the Main Stage
Hold an exhibit at this event
Showcase your Brand in Marketing Material
Gain exposure through alternative partnership benefits

event partners

CAI exist for one reason: To be the trusted solution for our clients as they strive to build a better working world and improve the human experience. We are 800+ global experts that bring top-tier expertise to every stage of a project, from creating comprehensive, detailed project plans to eliminating that last punch list item and beyond, into rigorous asset management, reliability, and sustainability activities. We are your choice regardless of your location.

Founded in Gothenburg, Sweden, Captario is a fast-growing software company catering to the pharmaceutical industry. Captario develops SUM® – Strategic Uncertainty Management, a cloud-based modeling & simulation software further empowered by AI and Machine Learning. It enables project and portfolio teams to base strategic decisions on a rich understanding of practically all possible futures. A team can compare options and gain new insights regarding trade-offs between time, cost, risk and value. The approach has consistently led drug project and portfolio teams to substantially increase the overall value. Captario SUM sets a new gold standard for strategic decision making in drug development. Ultimately, this leads to better and more affordable medicines to patients in need.

Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry.

Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making. We currently work with several of the largest global pharmaceutical companies, as well as with mid-size and smaller biotechnology companies. Diseases will impact nearly every individual. At Intelligencia, we work to make a difference.

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions create an organizational focus on the strategic outcomes that matter and empower teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,000 employees supporting 4,000 customers and 2.4 million users worldwide. For more information, visit www.planview.com.

Proggio is a Enterprise Project Portfolio Management solution for exceptional end-to-end portfolio visualization, alignment, and execution towards strategic goals.